Common use of Disclosure Controls Clause in Contracts

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 389 contracts

Sources: Underwriting Agreement (INNOCAN PHARMA Corp), Placement Agency Agreement (BriaCell Therapeutics Corp.), Placement Agency Agreement (Cel Sci Corp)

Disclosure Controls. The Company has developed and currently maintains an effective system of “disclosure controls and procedures procedures” (as defined in Rule 13a-15(e) of the Exchange Act) that will comply complies with Rule 13a-15 or 15d-15 under the requirements of the Exchange Act Regulations, and such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation extent required by Rule 13a-15(e) of the Company’s Exchange Act filings and other public disclosure documentsAct.

Appears in 163 contracts

Sources: Underwriting Agreement (Trailblazer Merger Corp I), Underwriting Agreement (Trailblazer Merger Corp I), Underwriting Agreement (Horizon Space Acquisition I Corp.)

Disclosure Controls. The Except as disclosed in the Registration Statement, Pricing Disclosure Package and the Prospectus, the Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 146 contracts

Sources: Underwriting Agreement (Libera Gaming Operations, Inc), Underwriting Agreement (GATES GROUP Inc.), Underwriting Agreement (TV Channels Network Inc.)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under of the Exchange Act RegulationsAct, and such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 99 contracts

Sources: Underwriting Agreement (Movano Inc.), Underwriting Agreement (Movano Inc.), Selling Agent Agreement (AzurRx BioPharma, Inc.)

Disclosure Controls. The Company has developed established and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 (as defined in Rules 13a-14 and 15d-14 under the Exchange Act Regulations, Act) and such controls and procedures are effective to ensure in ensuring that all material information concerning relating to the Company will be Company, including its subsidiaries, is made known on a timely basis to the individuals responsible for principal executive officer and the preparation principal financial officer. The Company has utilized such controls and procedures in preparing and evaluating the disclosures in the Registration Statement, in the Time of Sale Disclosure Package and in the Company’s Exchange Act filings and other public disclosure documentsProspectus.

Appears in 75 contracts

Sources: Underwriting Agreement (MamaMancini's Holdings, Inc.), Underwriting Agreement (Biolase, Inc), Underwriting Agreement (Biolase, Inc)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act RegulationsRegulations applicable to it, and such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 70 contracts

Sources: Underwriting Agreement (BRB Foods Inc.), Underwriting Agreement (BRB Foods Inc.), Underwriting Agreement (WF International Ltd.)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply in all material respects with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 59 contracts

Sources: Underwriting Agreement (Mega Fortune Co LTD), Underwriting Agreement (MPJS Group LTD), Underwriting Agreement (Mega Fortune Co LTD)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 54 contracts

Sources: Underwriting Agreement (DPW Holdings, Inc.), Underwriting Agreement (New Age Beverages Corp), Underwriting Agreement (Manhattan Bridge Capital, Inc)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply in all material respects with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and except as disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus, such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 48 contracts

Sources: Underwriting Agreement (Fatpipe Inc/Ut), Underwriting Agreement (Caring Brands, Inc.), Underwriting Agreement (RanMarine Technology B.V.)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act RegulationsAct, and such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 37 contracts

Sources: Underwriting Agreement (MaxsMaking Inc.), Underwriting Agreement (MaxsMaking Inc.), Underwriting Agreement (MaxsMaking Inc.)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply in all material respects with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and such controls and procedures are will be effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 28 contracts

Sources: Underwriting Agreement (K-Tech Solutions Co LTD), Underwriting Agreement (Green Solar Energy LTD), Underwriting Agreement (K-Tech Solutions Co LTD)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, applicable to it, and except as described in the Registration Statement, the Pricing Disclosure Package or Prospectus and such controls and procedures are effective as of the date hereof to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 18 contracts

Sources: Underwriting Agreement (Azitra, Inc.), Underwriting Agreement (Azitra Inc), Underwriting Agreement (MAIA Biotechnology, Inc.)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply in all material respects with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 15 contracts

Sources: Underwriting Agreement (Muscle Maker, Inc.), Underwriting Agreement (Laser Photonics Corp), Underwriting Agreement (Muscle Maker, Inc.)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, Regulations and such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 15 contracts

Sources: Placement Agency Agreement (Transcode Therapeutics, Inc.), Placement Agency Agreement (Roadzen Inc.), Placement Agency Agreement (Biovie Inc.)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act RegulationsRegulations applicable to it, and except as disclosed in the Registration Statement, the Pricing Prospectus and the Prospectus, such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 11 contracts

Sources: Underwriting Agreement (Guardion Health Sciences, Inc.), Underwriting Agreement (Guardion Health Sciences, Inc.), Underwriting Agreement (Guardion Health Sciences, Inc.)

Disclosure Controls. The Except as set forth in the SEC Documents, the Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act RegulationsAct, and such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 11 contracts

Sources: Securities Purchase Agreement (Galaxy Payroll Group LTD), Securities Purchase Agreement (Intelligent Group LTD), Securities Purchase Agreement (Inno Holdings Inc.)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and except as disclosed in the Company’s reports with the Commission, such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 10 contracts

Sources: Underwriting Agreement (Kaspien Holdings Inc.), Underwriting Agreement (Avinger Inc), Underwriting Agreement (Avinger Inc)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act RegulationsRegulations applicable to it, and, except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, such controls and procedures are as of the date hereof effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 9 contracts

Sources: Underwriting Agreement (HeartBeam, Inc.), Underwriting Agreement (HeartBeam, Inc.), Underwriting Agreement (Aditxt, Inc.)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and except as disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus, such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 8 contracts

Sources: Underwriting Agreement (Wetouch Technology Inc.), Underwriting Agreement (Wetouch Technology Inc.), Underwriting Agreement (Wetouch Technology Inc.)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and such controls and procedures are effective sufficient to ensure provide reasonable assurance that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 8 contracts

Sources: Underwriting Agreement (MDJM LTD), Underwriting Agreement (Puyi, Inc.), Underwriting Agreement (Agm Group Holdings, Inc.)

Disclosure Controls. The Other than as disclosed in the Incorporated Documents, the Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 8 contracts

Sources: Placement Agency Agreement, Underwriting Agreement (Cancer Genetics, Inc), Underwriting Agreement (NXT-Id, Inc.)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply is in material compliance with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, Regulations and such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s 's Exchange Act filings and other public disclosure documents.

Appears in 7 contracts

Sources: Placement Agency Agreement (Snow Lake Resources Ltd.), Placement Agency Agreement (Snow Lake Resources Ltd.), Placement Agency Agreement (Snow Lake Resources Ltd.)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act RegulationsAct, and such controls and procedures are effective to ensure that all material information concerning the Company will be are made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 7 contracts

Sources: Underwriting Agreement (Stemline Therapeutics Inc), Underwriting Agreement (Stemline Therapeutics Inc), Distribution Agreement (Stemline Therapeutics Inc)

Disclosure Controls. The Other than as disclosed in the SEC Filings, the Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 7 contracts

Sources: Underwriting Agreement (iBio, Inc.), Underwriting Agreement (iBio, Inc.), Underwriting Agreement (xG TECHNOLOGY, INC.)

Disclosure Controls. The Company has developed established and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 (as defined in Rules 13a-14 and 15d-14 under the Exchange Act Regulations, Act) and such controls and procedures are effective to ensure that in all material information concerning respects to perform the functions for which they were established. The Company will be made known on a timely basis to has utilized such controls and procedures in preparing and evaluating the individuals responsible for disclosures in the preparation Registration Statement, in the Time of Sale Disclosure Package and in the Company’s Exchange Act filings and other public disclosure documentsProspectus.

Appears in 7 contracts

Sources: Underwriting Agreement (Baudax Bio, Inc.), Underwriting Agreement (Baudax Bio, Inc.), Purchase Agreement (Zosano Pharma Corp)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply in all material respects with Rule 13a-15 or 15d-15 under the rules and regulations of the Commission under the Exchange Act (the “Exchange Act Regulations”), to the extent required under the Exchange Act Regulations, and any such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents, as applicable.

Appears in 6 contracts

Sources: Underwriting Agreement (Clip Interactive, LLC), Underwriting Agreement (Clip Interactive, LLC), Underwriting Agreement (Hancock Jaffe Laboratories, Inc.)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act RegulationsRegulations applicable to it, and such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 6 contracts

Sources: Underwriting Agreement (Biolase, Inc), Underwriting Agreement (Biolase, Inc), Underwriting Agreement (DarioHealth Corp.)

Disclosure Controls. The Except as disclosed in the Company’s Exchange Act filings, the Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 6 contracts

Sources: Underwriting Agreement (Cocrystal Pharma, Inc.), Underwriting Agreement (Opgen Inc), Underwriting Agreement (Boxlight Corp)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and applicable to it, and, except as described in the Registration Statement, the Pricing Disclosure Package or Prospectus, such controls and procedures are effective as of the date hereof to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 6 contracts

Sources: Underwriting Agreement (Tivic Health Systems, Inc.), Underwriting Agreement (Tivic Health Systems, Inc.), Underwriting Agreement (Tivic Health Systems, Inc.)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act RegulationsRegulations applicable to it, and such controls and procedures are effective to ensure provide reasonable assurance that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 5 contracts

Sources: Underwriting Agreement (Great Basin Scientific, Inc.), Underwriting Agreement (Vapor Corp.), Underwriting Agreement (Great Basin Scientific, Inc.)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and and, except as disclosed in the Registration Statement, such controls and procedures are effective to ensure that all material information concerning the Company and its Subsidiaries will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 5 contracts

Sources: Underwriting Agreement (Perfect Moment Ltd.), Underwriting Agreement (Lafayette Energy Corp.), Underwriting Agreement (Perfect Moment Ltd.)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under of the Exchange Act RegulationsAct, and such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 5 contracts

Sources: Placement Agent Agreement (Endurance Exploration Group, Inc.), Underwriting Agreement (General Agriculture Corp), Underwriting Agreement (General Agriculture Corp)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and except as disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus, such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 5 contracts

Sources: Underwriting Agreement (Entero Therapeutics, Inc.), Underwriting Agreement (iSpecimen Inc.), Underwriting Agreement (Shuttle Pharmaceuticals Holdings, Inc.)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act RegulationsRegulations applicable to it, and, except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, such controls and procedures are effective as of the date hereof to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 5 contracts

Sources: Underwriting Agreement (FG Group Holdings Inc.), Underwriting Agreement (Strong Global Entertainment, Inc.), Underwriting Agreement (Strong Global Entertainment, Inc)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act Regulationsand the Rules and Regulations applicable to it, and such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 5 contracts

Sources: Underwriting Agreement (Aldeyra Therapeutics, Inc.), Underwriting Agreement (Aldeyra Therapeutics, Inc.), Underwriting Agreement (Aldeyra Therapeutics, Inc.)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and such controls and procedures are effective to ensure that all material information concerning the Company will be is made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 5 contracts

Sources: Underwriting Agreement (LMP Automotive Holdings, Inc.), Underwriting Agreement (LMP Automotive Holdings, Inc.), Underwriting Agreement (RumbleON, Inc.)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and applicable to it, and, except as described in the Registration Statement, the Pricing Disclosure Package or Prospectus, such controls and procedures are effective as of the date hereof to ensure provide reasonable assurance that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 4 contracts

Sources: Underwriting Agreement (Inhibikase Therapeutics, Inc.), Underwriting Agreement (Inhibikase Therapeutics, Inc.), Underwriting Agreement (Inhibikase Therapeutics, Inc.)

Disclosure Controls. The Company has developed and currently maintains established disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 4 contracts

Sources: Underwriting Agreement (1347 Property Insurance Holdings, Inc.), Underwriting Agreement (1347 Property Insurance Holdings, Inc.), Underwriting Agreement (Evoke Pharma Inc)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply is in material compliance with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 4 contracts

Sources: Placement Agency Agreement (BriaCell Therapeutics Corp.), Placement Agency Agreement (BriaCell Therapeutics Corp.), Placement Agency Agreement (Vision Marine Technologies Inc.)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and such controls and procedures are effective to ensure that all material information concerning the Company will be are made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 4 contracts

Sources: Underwriting Agreement (Myomo Inc), Underwriting Agreement (RumbleON, Inc.), Underwriting Agreement (RumbleON, Inc.)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and and, except as disclosed in the Registration Statement such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 4 contracts

Sources: Underwriting Agreement (Forza X1, Inc.), Underwriting Agreement (Twin Vee PowerCats, Co.), Underwriting Agreement (Forza X1, Inc.)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and such controls and procedures are effective to ensure that all material information concerning the Company and each member of the Company Group will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 4 contracts

Sources: Underwriting Agreement (Eyegate Pharmaceuticals Inc), Underwriting Agreement (Eyegate Pharmaceuticals Inc), Underwriting Agreement (Eyegate Pharmaceuticals Inc)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act RegulationsRegulations applicable to it, and such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s 's Exchange Act filings and other public disclosure documents.

Appears in 4 contracts

Sources: Underwriting Agreement (PetroShare Corp.), Underwriting Agreement (PetroShare Corp.), Underwriting Agreement (PetroShare Corp.)

Disclosure Controls. The Other than as disclosed in our SEC Filings, the Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 4 contracts

Sources: Placement Agency Agreement (Sphere 3D Corp), Placement Agency Agreement (xG TECHNOLOGY, INC.), Placement Agency Agreement (xG TECHNOLOGY, INC.)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and except as disclosed in the Registration Statement, the Disclosure Package and the Preliminary Prospectus, such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 4 contracts

Sources: Underwriting Agreement (Global Backbone Technology Ltd.), Underwriting Agreement (Beroni Group LTD), Underwriting Agreement (Immuron LTD)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply in all material respects with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 4 contracts

Sources: Underwriting Agreement (LQR House Inc.), Underwriting Agreement (LQR House Inc.), Underwriting Agreement (LQR House Inc.)

Disclosure Controls. The Company has developed is using commercially reasonable efforts to develop and currently maintains maintain disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act RegulationsRegulations and address the weaknesses described in the Registration Statement, the Disclosure Package and the Prospectus, and such controls and procedures are will be effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 3 contracts

Sources: Underwriting Agreement (Cytosorbents Corp), Underwriting Agreement (Cytosorbents Corp), Underwriting Agreement (Cytosorbents Corp)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply in all material respects with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and such controls and procedures are will be effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s 's Exchange Act filings and other public disclosure documents.

Appears in 3 contracts

Sources: Underwriting Agreement (Aduro Clean Technologies Inc.), Underwriting Agreement (Aduro Clean Technologies Inc.), Underwriting Agreement

Disclosure Controls. The Company has developed and currently maintains will maintain, when applicable, disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and such controls and procedures are will, when applicable, be effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 3 contracts

Sources: Underwriting Agreement, Underwriting Agreement (Draganfly Inc.), Underwriting Agreement (Draganfly Inc.)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply in material compliance with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and such controls and procedures are reasonably effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 3 contracts

Sources: Underwriting Agreement (Shineco, Inc.), Underwriting Agreement (NRX Pharmaceuticals, Inc.), Underwriting Agreement (NRX Pharmaceuticals, Inc.)

Disclosure Controls. The Company has developed and currently maintains an effective system of “disclosure controls and procedures procedures” (as defined in Rule 13a-15(e) of the Exchange Act) that will comply complies with Rule 13a-15 or 15d-15 under the requirements of the Exchange Act Regulationsapplicable to it, and such controls and procedures are effective to ensure that all material information concerning the Company and its Subsidiaries will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 3 contracts

Sources: Underwriting Agreement (D. Medical Industries Ltd.), Underwriting Agreement (D. Medical Industries Ltd.), Underwriting Agreement (D. Medical Industries Ltd.)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply in compliance with Rule 13a-15 or 15d-15 under the Exchange Act RegulationsRegulations applicable to it, and such controls and procedures are reasonably effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 3 contracts

Sources: Underwriting Agreement (Staffing 360 Solutions, Inc.), Underwriting Agreement (Staffing 360 Solutions, Inc.), Underwriting Agreement (Staffing 360 Solutions, Inc.)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under of the Exchange Act Regulations, and such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documentsAct.

Appears in 3 contracts

Sources: Underwriter Agreement (Dogness (International) Corp), Placement Agreement (Hebron Technology Co., LTD), Placement Agreement (Hebron Technology Co., LTD)

Disclosure Controls. The Except as disclosed in the Registration Statement and the Prospectus, the Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act Regulationsand regulations applicable to it, and such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 3 contracts

Sources: Underwriting Agreement (EvoAir Holdings Inc.), Underwriting Agreement (EvoAir Holdings Inc.), Underwriting Agreement (EvoAir Holdings Inc.)

Disclosure Controls. The Company has developed and currently maintains will maintain disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and such controls and procedures are effective have been designed to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 3 contracts

Sources: Underwriting Agreement (Auddia Inc.), Underwriting Agreement (Vallon Pharmaceuticals, Inc.), Underwriting Agreement (Vallon Pharmaceuticals, Inc.)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply in all material respects with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and and, no later than March 31, 2021, such controls and procedures are shall be effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 3 contracts

Sources: Underwriting Agreement (Ammo, Inc.), Underwriting Agreement (Ammo, Inc.), Underwriting Agreement (Ammo, Inc.)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act RegulationsAct, and such controls and procedures are effective to ensure that all material information concerning the Company will be is made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 3 contracts

Sources: Underwriting Agreement (BioLineRx Ltd.), Underwriting Agreement (BiondVax Pharmaceuticals Ltd.), Underwriting Agreement (BioLineRx Ltd.)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act RegulationsAct, and such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 2 contracts

Sources: Equity Distribution Agreement (Synalloy Corp), Equity Distribution Agreement (Synalloy Corp)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act Regulations. Except as disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus, such controls and procedures are reasonably effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 2 contracts

Sources: Underwriting Agreement (Tapinator, Inc.), Underwriting Agreement (Tapinator, Inc.)

Disclosure Controls. The Company has developed and is currently maintains developing its disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act RegulationsRegulations applicable to the Company, and such controls and procedures are will be effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 2 contracts

Sources: Underwriting Agreement (CapsoVision, Inc), Underwriting Agreement (CapsoVision, Inc)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply in all material respects with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and except as disclosed in the Company’s reports with the Commission, such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 2 contracts

Sources: Underwriting Agreement (My Size, Inc.), Underwriting Agreement (My Size, Inc.)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and except as described in the Registration Statement, the Disclosure Package and the Prospectus, such controls and procedures are effective to ensure that all material information concerning the Company will be is made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 2 contracts

Sources: Underwriting Agreement (Biovie Inc.), Underwriting Agreement (Hepion Pharmaceuticals, Inc.)

Disclosure Controls. The Company has developed established and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 required by Rules 13a-15(e) or 15d-15 under 15d-15(e) of the Exchange Act Regulations, and such controls and procedures are effective to ensure that all material information concerning relating to the Company will and its Subsidiaries required to be made known on a timely basis disclosed by the Company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and is accumulated and communicated to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documentsmanagement to allow timely decisions regarding required disclosure.

Appears in 2 contracts

Sources: Merger Agreement (Micron Technology Inc), Merger Agreement (Lexar Media Inc)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, such controls and procedures are effective to ensure that all material information concerning the Company will be is made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 2 contracts

Sources: Underwriting Agreement (Hepion Pharmaceuticals, Inc.), Underwriting Agreement (Hepion Pharmaceuticals, Inc.)

Disclosure Controls. The Company has and each of its subsidiaries have developed and currently maintains maintain disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act Regulationsapplicable to it, and such controls and procedures are effective to ensure that all material information concerning the Company or its subsidiaries, as applicable, will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 2 contracts

Sources: Open Market Sale Agreement (Aldeyra Therapeutics, Inc.), Open Market Sale Agreement (Aldeyra Therapeutics, Inc.)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and such controls and procedures are will be effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 2 contracts

Sources: Underwriting Agreement (Rich Sparkle Holdings LTD), Underwriting Agreement (Rich Sparkle Holdings LTD)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under of the Exchange Act RegulationsAct, and such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s 's Exchange Act filings and other public disclosure documents.

Appears in 2 contracts

Sources: Underwriting Agreement (Education Media, Inc.), Underwriting Agreement (Fusion Telecommunications International Inc)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply in all material respects with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and except as disclosed in the Registration Statement, the Pricing Disclosure Package, and the Prospectus, such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 2 contracts

Sources: Underwriting Agreement (Treasure Global Inc), Underwriting Agreement (Treasure Global Inc)

Disclosure Controls. The Other than as disclosed in our SEC filings, the Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 2 contracts

Sources: Equity Distribution Agreement (Ion Geophysical Corp), Equity Distribution Agreement (xG TECHNOLOGY, INC.)

Disclosure Controls. The Company has and each of its subsidiaries have developed and currently maintains maintain disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act Regulationsand the Rules and Regulations applicable to it, and such controls and procedures are effective to ensure that all material information concerning the Company or its subsidiaries, as applicable, will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 2 contracts

Sources: Underwriting Agreement (Aldeyra Therapeutics, Inc.), Underwriting Agreement (Aldeyra Therapeutics, Inc.)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and such controls and procedures are expected, upon the Effective Date, to be effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 2 contracts

Sources: Underwriting Agreement (Helio Corp /FL/), Underwriting Agreement (Helio Corp /FL/)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with the applicable provisions of Rule 13a-15 or 15d-15 under of the Exchange Act Regulationsand, and to the extent applicable, such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 2 contracts

Sources: Selling Agent Agreement (Alliance MMA, Inc.), Selling Agent Agreement (Alliance MMA, Inc.)

Disclosure Controls. The Company has developed established and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 required by Rules 13a-15(e) or 15d-15 15d-15(e) under the Exchange Act Regulations, and such controls and procedures that are effective designed to ensure that all material information concerning required to be disclosed by the Company will be made known on a timely basis in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and is accumulated and communicated to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documentsmanagement to allow timely decisions regarding required disclosure.

Appears in 2 contracts

Sources: Merger Agreement (Solectron Corp), Merger Agreement (Flextronics International Ltd.)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and such controls and procedures are effective designed to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 2 contracts

Sources: Underwriting Agreement (SurgePays, Inc.), Underwriting Agreement (IceCure Medical Ltd.)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply and is in compliance with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 2 contracts

Sources: Underwriting Agreement (Nova Minerals LTD), Underwriting Agreement (Nova Minerals LTD)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act RegulationsAct, and such controls and procedures currently are not effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents. The Company intends to implement remedial measures designed to address the ineffectiveness of its disclosure controls and procedures.

Appears in 2 contracts

Sources: Underwriting Agreement (Northwest Biotherapeutics Inc), Underwriting Agreement (Northwest Biotherapeutics Inc)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 2 contracts

Sources: Underwriting Agreement (Aureus Greenway Holdings Inc), Underwriting Agreement (Aureus Greenway Holdings Inc)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and such controls and procedures are effective to ensure that all material information concerning the Company and each member of the Company Group will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 2 contracts

Sources: Underwriting Agreement (Eyegate Pharmaceuticals Inc), Underwriting Agreement (Eyegate Pharmaceuticals Inc)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply in all material respects with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and and, no later than March 31, 2022, such controls and procedures are were effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 2 contracts

Sources: Underwriting Agreement (BitNile Holdings, Inc.), Underwriting Agreement (BitNile Holdings, Inc.)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will materially comply with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 2 contracts

Sources: Underwriting Agreement (Linkage Global Inc), Underwriting Agreement (Linkage Global Inc)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will are designed to comply with Rule 13a-15 or 15d-15 under the requirements of the Exchange Act Regulations, and such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 2 contracts

Sources: Underwriting Agreement (DERMAdoctor, Inc.), Underwriting Agreement (DERMAdoctor, LLC)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act RegulationsRegulations applicable to it, and such controls and procedures are reasonably effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 2 contracts

Sources: Underwriting Agreement (PeerStream, Inc.), Underwriting Agreement (PeerStream, Inc.)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act RegulationsRegulations applicable to it, and, except as described in the SEC Reports, Registration Statement, the Pricing Disclosure Package and the Prospectus, such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 2 contracts

Sources: Underwriting Agreement (Trxade Group, Inc.), Underwriting Agreement (Trxade Group, Inc.)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents. These disclosure controls are different from the internal controls on financial reporting to which the Company’s material weakness relates, as described in the Registration Statement, the Pricing Disclosure Package and Prospectus.

Appears in 2 contracts

Sources: Underwriting Agreement (Beamr Imaging Ltd.), Underwriting Agreement (Beamr Imaging Ltd.)

Disclosure Controls. The Except as disclosed in the Company’s Exchange Act filings, the Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 2 contracts

Sources: Underwriting Agreement (Verb Technology Company, Inc.), Underwriting Agreement (Verb Technology Company, Inc.)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and except as set forth or incorporated by reference in the Registration Statement, the Pricing Disclosure Package or the Prospectus, such controls and procedures are effective to ensure that all material information concerning the Company will be are made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 1 contract

Sources: Underwriting Agreement (Workhorse Group Inc.)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange 1934 Act Regulations, and such controls and procedures are effective designed to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange 1934 Act filings and other public disclosure documents.

Appears in 1 contract

Sources: At the Market Offering Agreement (SurgePays, Inc.)

Disclosure Controls. The Company has developed and currently maintains adequate disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act Regulationsprocedures, and such controls and procedures are effective to ensure that all material information concerning the Company pursuant to Regulation A and other applicable Commission rules and regulations will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 1 contract

Sources: Placement Agency Agreement (Campagna Motors USA Inc.)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under of the Exchange Act Regulations, and Act; such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents; and such disclosure controls and procedures are effective in all material respects to perform the functions for which they were established.

Appears in 1 contract

Sources: Underwriting Agreement (Hyperdynamics Corp)

Disclosure Controls. The After the offering, the Company has developed will develop and currently maintains maintain disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and such controls and procedures are will be effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 1 contract

Sources: Underwriting Agreement (HyreCar Inc.)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s 's Exchange Act filings and other public disclosure documents.

Appears in 1 contract

Sources: Underwriting Agreement (ImmunoPrecise Antibodies Ltd.)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with (as such term is defined in Rule 13a-15 or 15d-15 under 13a-15(e) of the Exchange Act Regulations, and such controls and procedures Rules) that are effective designed to ensure that all material information concerning comply with the Company will be made known on a timely basis to the individuals responsible for the preparation applicable requirements of the Company’s Exchange Act filings and other public Act. The Company has conducted evaluations of the effectiveness of its disclosure documentscontrols as required by Rule 13a-15 of the Exchange Act.

Appears in 1 contract

Sources: Sales Agreement (Intercept Pharmaceuticals, Inc.)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will are designed to comply with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and except as set forth in the Incorporated Documents such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 1 contract

Sources: Underwriting Agreement (Atossa Genetics Inc)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act Regulationsapplicable to it, and such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 1 contract

Sources: Open Market Sale Agreement (Aldeyra Therapeutics, Inc.)

Disclosure Controls. The Except as disclosed in the SEC Reports and the Prospectus, the Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 1 contract

Sources: Underwriting Agreement (KULR Technology Group, Inc.)

Disclosure Controls. The Company has developed and currently maintains designed disclosure controls and procedures that will comply with as defined in Rule 13a-15 or 15d-15 under the Exchange Act RegulationsAct, and such controls and procedures are effective to ensure that all material information concerning relating to the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documentsfilings.

Appears in 1 contract

Sources: Underwriting Agreement (Professional Diversity Network, LLC)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply in all material respects with Rule 13a-15 or 15d-15 under of the Exchange Act Regulations, and such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 1 contract

Sources: Underwriting Agreement (G Medical Innovations Holdings Ltd.)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.

Appears in 1 contract

Sources: Underwriting Agreement (Lirum Therapeutics, Inc.)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, where applicable, and such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents, except as otherwise disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus.

Appears in 1 contract

Sources: Underwriting Agreement (QMSK Technology Co., LTD)

Disclosure Controls. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and except as disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus, such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents...

Appears in 1 contract

Sources: Underwriting Agreement (Mixed Martial Arts Group LTD)